Predictors of successful defibrillation threshold test during CRT-D implantation

Kardiologia Polska

Volumn 68, Issue 5, 2010, Pages 512-518

  Przybylski, Andrzej ^a   Orȩziak, Artur ^a   Lewandowski, Zbigniew ^b   Hasiec, Andrzej ^a   Orczykowski, Michał ^a   Walczak, Franciszek ^a  

^a INSTITUTE OF CARDIOLOGY   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Cardiac resynchronisation therapy; Defibrillation; Implantable cardioverter defibrillators

Indexed keywords

ADULT; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; DEFIBRILLATION; DEFIBRILLATOR; FEMALE; FOLLOW UP; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; IMPLANTATION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; WAVEFORM;

EID: 77953797173     PISSN: 00229032     EISSN: 00229032     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Eksperci ACC/AHA/ESC. Wytyczne dotycza̧ce postȩpowania u chorych z komorowymi zaburzeniami rytmu serca i zapobiegania nagłemu zgonowi sercowemu; wersja skrócona. Kardiol Pol, 2006; 64: 1373-1415.
2. Kroll MW, Tchou PJ. Testing of implantable defibrillator functions at implantation. In: Ellenbogen KA, Kay GN, Wilkoff BL eds. Clinical cardiac pacing and defibrillation. WB Saunders, Philadelphia 2000: 540-561.
3. Ideker RE, Epstein AE, Plumb VJ. Should shocks still be administered during implantable cardioverter defibrillatro insertion? Heart Rhythm, 2005; 2: 462-463.
4. Swerdlow CD. Reappraisal of implant testing of implantable cardioverter defibrillators. J Am Coll Cardiol, 2004; 44: 92-94. (Pubitemid 38968464)
5. Strickberger SA, Klein GJ. Is defibrillation testing required for defibrillator implantation? J Am Coll Cardiol, 2004; 44: 88-91.
6. Swerdlow CD, Russo AM, Degroot PJ. The dilemma of ICD implant testing. Pacing Clin Electrophysiol, 2007; 30: 675-700.
7. Lubiński A, Lewicka-Nowak E, Zienciuk A et al. Clinical predictors of defibrillation threshold in patients with implantable cardioverter- defibrillators. Kardiol Pol, 2005; 62: 317-328.
8. Shukla HH, Flaker GC, Jayam V, Roberts D. High defibrillation thresholds in transvenous biphasic implantable defibrillators: clinical predictors and prognostic implications. Pacing Clin Electrophysiol, 2003; 26: 44-48. (Pubitemid 36398755)
9. Russo AM, Sauer W, Gerstenfeld EP et al. Defibrillation threshold testing: is it really necessary at the time of implantable cardioverter- defibrillator insertion? Heart Rhythm, 2005; 2: 456-461.
10. Vardas PE, Auricchio A, Blanc JJ et al. Guidelines for cardiac pacing and cardiac resynchronization therapy. The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association. Europace, 2007; 9: 959-998.
11. Przybylski A, Sterliński M. Implantowane kardiowertery- defibrylatory. Wydawnictwo A i M, Warszawa 2006.
12. Day JD, Olshansky B, Moore S et al. INTRINSIC RV Study Investigators. High defibrillation energy requirements are encountered rarely with modern dual-chamber implantable cardioverter-defibrillator systems. Europace, 2008; 10: 347-350.
13. Hohnloser SH, Dorian P, Roberts R et al. Effect of amiodarone and sotalol on ventricular defibrillation threshold: the optimal pharmacological therapy in cardioverter defibrillator patients (OPTIC) trial. Circulation, 2006; 114: 104-109.
14. Schuger C, Ellenbogen KA, Faddis M et al. Defibrillation energy requirements in an ICD population receiving cardiac resynchronization therapy. J Cardiovasc Electrophysiol, 2006; 17: 247-250.
15. Wase A, Basit A, Nazir R et al. Impact of chronic kidney disease upon survival among implantable cardioverter-defibrillator recipients. J Interv Card Electrophysiol, 2004; 11: 199-204.
16. Turakhia MP, Varosy PD, Lee K et al. Impact of renal function on survival in patients with implantable cardioverter-defibrillators. Pacing Clin Electrophysiol, 2007; 30: 377-384.
17. Levy R, DellaValle A, Atav AS et al. The relationship between glomerular filtration rate and survival in patients treated with an implantable cardioverter defibrillator. Clin Cardiol, 2008; 31: 265-269.
18. Cygankiewicz I, Gillespie J, Zareba W et al. MADIT II Investigators. Predictors of long-term mortality in Multicenter Automatic Defibrillator Implantation Trial II (MADIT II) patients with implantable cardioverter- defibrillators. Heart Rhythm, 2009; 6: 468-473.
19. Mouchawar G, Kroll M, Val-Mejias JE. ICD waveform optimization: a randomized, prospective, pair-sampled multicenter study. Pacing Clin Electrophysiol, 2000; 23: 1992-1995.
20. Kroll MW, Efimov IR, Tchou PJ. Present understanding of shock polarity for internal defibrillation: the obvious and non-obvious clinical implications. Pacing Clin Electrophysiol, 2006; 29: 885-891.
21. Zienciuk A, Lubiński A, Królak T et al. Effects of shock polarity reversal on defibrillation threshold in an implantable cardioverter-defibrillator. Kardiol Pol, 2007; 65: 495-500.
22. Merkely B, Lubiński A, Kiss O et al. Shortening the second phase duration of biphasic shocks: effects of class III antiarrhythmic drugs on defibrillation efficacy in humans. J Cardiovasc Electrophysiol, 2001; 12: 828-829.
23. Osswald BR, De Simone R, Most S et al. High defibrillation threshold in patients with implantable defibrillator: how effective is the subcutaneous finger lead? Eur J Cardiothorac Surg, 2009; 35: 489-492.